Zacks Investment Research upgraded shares of Kindred Healthcare, Inc. (NYSE:KND) from a sell rating to a hold rating in a research report released on Friday morning.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

KND has been the subject of a number of other reports. Mizuho reiterated a neutral rating and set a $9.00 target price on shares of Kindred Healthcare in a report on Monday, July 3rd. BidaskClub lowered shares of Kindred Healthcare from a buy rating to a hold rating in a report on Wednesday, July 12th. Royal Bank Of Canada reiterated a hold rating and set a $10.00 target price on shares of Kindred Healthcare in a report on Monday, May 15th. Barclays PLC reiterated a buy rating and set a $13.00 target price (up from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. Finally, UBS AG reiterated a neutral rating and set a $10.50 target price (up from $8.00) on shares of Kindred Healthcare in a report on Friday, May 5th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $9.94.

Kindred Healthcare (NYSE:KND) opened at 7.50 on Friday. The company’s market capitalization is $652.64 million. The stock has a 50 day moving average price of $10.14 and a 200 day moving average price of $9.23. Kindred Healthcare has a 52-week low of $5.65 and a 52-week high of $11.90.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business posted $0.38 earnings per share. The company’s revenue was down 4.6% on a year-over-year basis. Equities research analysts forecast that Kindred Healthcare will post $0.57 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Kindred Healthcare, Inc. (KND) Upgraded to Hold at Zacks Investment Research” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/15/kindred-healthcare-inc-knd-upgraded-to-hold-at-zacks-investment-research.html.

A number of institutional investors have recently added to or reduced their stakes in the company. State Street Corp increased its position in Kindred Healthcare by 5.2% in the second quarter. State Street Corp now owns 2,336,912 shares of the health services provider’s stock worth $27,219,000 after buying an additional 114,598 shares during the last quarter. Janus Henderson Group PLC bought a new position in Kindred Healthcare during the second quarter worth about $130,000. AHL Partners LLP increased its position in Kindred Healthcare by 63.4% in the second quarter. AHL Partners LLP now owns 79,184 shares of the health services provider’s stock worth $922,000 after buying an additional 30,724 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Kindred Healthcare by 102.3% in the second quarter. Goldman Sachs Group Inc. now owns 1,753,787 shares of the health services provider’s stock worth $20,431,000 after buying an additional 886,906 shares during the last quarter. Finally, QS Investors LLC increased its position in Kindred Healthcare by 4.0% in the second quarter. QS Investors LLC now owns 266,321 shares of the health services provider’s stock worth $3,103,000 after buying an additional 10,233 shares during the last quarter. 89.79% of the stock is owned by institutional investors.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.